Darts failing to hit bullseye
Biotech

2025's top 10 clinical trial flops

Fierce Biotech looks back at 10 of the most impactful and interesting clinical failures of 2025.
partnership collaboration legal document

CSL inks $328M Memo deal for option on antibody engineering tech

Feb 9, 2026 2:00am
Article Primary Image 1jpg

The Data Multiplier Effect: The 4 Forces Changing Biometrics

Feb 9, 2026 8:00am
Grouping of tiles with human figures on them being separated representing layoffs

Genentech cut at least 489 jobs last year, new filing reveals

Feb 6, 2026 1:38pm
pause button on blue background

UniQure halts mid- to high-dosing for AAV gene therapy

Feb 6, 2026 10:56am
Parachute over ocean with sunset behind

Moderna CMO steps down in leadership mix-up—Chutes & Ladders

Feb 6, 2026 8:30am
More News

Priovant will move brepocitinib to phase 3 after midstage win

Feb 6, 2026 7:00am

Agomab, SpyGlass head to Nasdaq with IPOs totaling $350M

Feb 6, 2026 4:04am

Fierce Biotech Layoff Tracker 2026: ARPA-H, GSK & more

Feb 5, 2026 2:55pm

Racing BMS and J&J, Bayer ties asundexian to 26% stroke decrease

Feb 5, 2026 12:15pm